• Booth: 3318

Predictive Organ-on-a-Chip models for new & better therapies

MIMETAS, a Leiden-based microfluidics company founded in 2013, develops Organ-on-a-Chip technology for high‐throughput testing of new medicines in more predictive miniaturized organ models. MIMETAS is world-leading in passive microfluidics and has a unique OrganoPlate ™ technology based on a proprietary microfluidic liquid handling technique called PhaseGuides™, enabling membrane-free in vitro 3D co-culture models with continuous perfusion for a large variety of tissues and diseases.

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".